News Shire to Resubmit Dry-Eye Disease Drug to FDA With New Study Data by Medscape • 2015/10/28 • 0 Comments Shire said its dry-eye disease drug lifitegrast significantly improved patient symptoms in a new study, supporting a re-submission of the medicine to U.S. regulators early next year. Reuters Health Information Full Story →